Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases
dc.contributor.author | Karahan, S. Zengin | |
dc.contributor.author | Boz, C. | |
dc.contributor.author | Saip, S. | |
dc.contributor.author | Kale, N. | |
dc.contributor.author | Demirkaya, S. | |
dc.contributor.author | Celik, Y. | |
dc.contributor.author | Demir, S. | |
dc.contributor.author | Kurne, A. | |
dc.contributor.author | Terzi, M. | |
dc.contributor.buuauthor | Ozbek, S. Erer | |
dc.contributor.department | Bursa Uludağ Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri/Nöroloji Bölümü. | tr_TR |
dc.contributor.scopusid | 55325044500 | tr_TR |
dc.date.accessioned | 2023-06-09T13:07:55Z | |
dc.date.available | 2023-06-09T13:07:55Z | |
dc.date.issued | 2019-08 | |
dc.description.abstract | Susac's Syndrome (SS), which was first described in 1979, is a rare and presumably autoimmune disorder characterized by encephalopathy, hearing loss, and visual disturbance resulting from branch retinal artery occlusion (BRAO). This study reports 19 SS patients' clinical characteristics, MRI features, CSF analysis, treatment strategies and outcomes. At initial presentation, only three of 19 patients demonstrated the complete clinical triad. Clinic presentation varied from isolated hemiparesis to the full triad (encephalopathy, hearing loss and visual disturbances). Corpus callosum (CC) involvement was noted in the MRI of 18 patients (97%) and BRAO was detected in 17 (95%) patients. All patients were treated with intravenous methylprednisolone after the initial assessment. This case series is presented to emphasize the differences in clinical presentation of SS and the importance of MRI and FFA in diagnosis. | en_US |
dc.identifier.citation | Karahan, S. Z. vd. (2019). ''Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases''. Multiple sclerosis and relared disorders, 33, 94-99. | en_US |
dc.identifier.endpage | 99 | tr_TR |
dc.identifier.issn | 2211-0348 | |
dc.identifier.issn | 2211-0356 | |
dc.identifier.pubmed | 31176296 | tr_TR |
dc.identifier.scopus | 2-s2.0-85066635402 | tr_TR |
dc.identifier.startpage | 94 | tr_TR |
dc.identifier.uri | https://doi.org/10.1016/j.msard.2019.05.018 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S2211034819302226 | |
dc.identifier.uri | http://hdl.handle.net/11452/33003 | |
dc.identifier.volume | 33 | tr_TR |
dc.identifier.wos | 000475740000018 | tr_TR |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.journal | Multiple sclerosis and relared disorders | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Susac syndrome | en_US |
dc.subject | Corpus callosum | en_US |
dc.subject | Branch retinal artery occlusion | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject.emtree | Azathioprine | en_US |
dc.subject.emtree | Cyclophosphamide | en_US |
dc.subject.emtree | Immunoglobulin | en_US |
dc.subject.emtree | Methylprednisolone | en_US |
dc.subject.emtree | Mycophenolate mofetil | en_US |
dc.subject.emtree | Antiinflammatory agent | en_US |
dc.subject.emtree | Methylprednisolone | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Brain disease | en_US |
dc.subject.emtree | Branch retinal artery occlusion | en_US |
dc.subject.emtree | Cerebrospinal fluid analysis | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Clinical feature | en_US |
dc.subject.emtree | Convalescence | en_US |
dc.subject.emtree | Corpus callosum | en_US |
dc.subject.emtree | Diagnostic procedure | en_US |
dc.subject.emtree | Drug pulse therapy | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Hearing impairment | en_US |
dc.subject.emtree | Hemiparesis | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Nuclear magnetic resonance imaging | en_US |
dc.subject.emtree | Retina fluorescein angiography | en_US |
dc.subject.emtree | Susac syndrome | en_US |
dc.subject.emtree | Treatment outcome | en_US |
dc.subject.emtree | Visual impairment | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Fluorescence angiography | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Pathology | en_US |
dc.subject.emtree | Procedures | en_US |
dc.subject.emtree | Retrospective study | en_US |
dc.subject.emtree | Susac syndrome | en_US |
dc.subject.emtree | Young adult | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Anti-Inflammatory Agents | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Fluorescein Angiography | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Magnetic Resonance Imaging | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Methylprednisolone | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Retrospective Studies | en_US |
dc.subject.mesh | Susac Syndrome | en_US |
dc.subject.mesh | Young Adult | en_US |
dc.subject.scopus | Susac Syndrome; Fluorescence Angiography; Audiometry | en_US |
dc.subject.wos | Clinical neurology | en_US |
dc.title | Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases | en_US |
dc.type | Editorial Material | |
dc.wos.quartile | Q2 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: